Semaglutide vs Tirzepatide

Why people compare these. These are the two most-searched names in metabolic care and are frequently compared head-to-head. Unlike most topics in the Vitrex index, both have substantial human trial evidence and approved products — which makes the provider’s eligibility assessment, not the evidence base, the deciding factor.

Medically reviewed by Bernard Garcia, MD

Semaglutide

Tirzepatide

What it is

Semaglutide A GLP-1 receptor agonist — a medicine that mimics a hormone involved in appetite and blood-sugar regulation.

Tirzepatide A dual GIP and GLP-1 receptor agonist — it acts on two related hormone pathways rather than one.

Research context

Semaglutide Studied in large, placebo-controlled human trials. FDA-approved products exist for specific uses in type 2 diabetes and chronic weight management, with defined eligibility criteria.

Tirzepatide Studied in large, placebo-controlled human trials. FDA-approved products exist for specific uses in type 2 diabetes and chronic weight management, with defined eligibility criteria.

Research status

Semaglutide Large human trials · FDA-approved for specific uses

Tirzepatide Large human trials · FDA-approved for specific uses

Typically discussed for

Semaglutide Metabolic and weight-management conversations

Tirzepatide Metabolic and weight-management conversations

How they differ

Mechanism. Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both the GIP and GLP-1 receptors. Whether that difference matters for a given person is a clinical judgment, not a rule.

Evidence. Both have been studied in large trials and compared directly in head-to-head research. Results in a trial population do not predict results for an individual, and neither is appropriate for everyone.

Eligibility and safety. Approved products carry specific indications, contraindications, and monitoring requirements. Personal and family medical history — including thyroid, pancreatic, and gastrointestinal history — strongly affects whether either is suitable. That assessment is the whole point of provider review.

Compounded versions. Compounded preparations are not FDA-approved products and are subject to different oversight. Ask a provider what exactly is being discussed and where it comes from.

Questions for a provider

Do I meet the eligibility criteria for either, based on my history and measurements?
Is there anything in my personal or family history that rules one or both out?
What monitoring, labs, and follow-up would be involved, and how often?
If a compounded product is discussed, what is it, where is it made, and what oversight applies?

Which is right for you?

Neither this page nor any website can answer that. The comparison exists so your conversation with a licensed provider starts from an informed place; the provider decides what, if anything, is appropriate after a confidential intake.

Discuss both with a provider

Free · about 10 minutes · reviewed by a licensed physician

General education · Not medical advice · Provider approval required